Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?
Authors:
- 1 November 2019
- journal article
- review article
- Published by Elsevier in Molecular Pharmacology
- Vol. 96 (5) , 527-541
Abstract
The ligand-binding sites of many G protein-coupled receptors (GPCRs) are situated around and deeply embedded within the central pocket formed by their seven transmembrane-spanning α-helical domains. Generally, these binding sites are assumed accessible to endogenous ligands from the aqueous phase. Recent advances in the structural biology of GPCRs, along with biophysical and computational studies, suggest that amphiphilic and lipophilic molecules may gain access to these receptors by first partitioning into the membrane and then reaching the binding site via lateral diffusion through the lipid bilayer. In addition, several crystal structures of class A and class B GPCRs bound to their ligands offer unprecedented details on the existence of lipid-facing allosteric binding sites outside the transmembrane helices that can only be reached via lipid pathways. The highly organized structure of the lipid bilayer may direct lipophilic or amphiphilic drugs to a specific depth within the bilayer, changing local concentration of the drug near the binding site and affecting its binding kinetics. Additionally, the constraints of the lipid bilayer, including its composition and biophysical properties, may play a critical role in “pre-organizing” ligand molecules in an optimal orientation and conformation to facilitate receptor binding. Despite its clear involvement in molecular recognition processes, the critical role of the membrane in binding ligands to lipid-exposed transmembrane binding sites remains poorly understood and warrants comprehensive investigation. Understanding the mechanistic basis of the structure-membrane interaction relationship of drugs will not only provide useful insights about receptor binding kinetics but will also enhance our ability to take advantage of the apparent membrane contributions when designing drugs that target transmembrane proteins with improved efficacy and safety. In this minireview, we summarize recent structural and computational studies on membrane contributions to binding processes, elucidating both lipid pathways of ligand access and binding mechanisms for several orthosteric and allosteric ligands of class A and class B GPCRs.Keywords
This publication has 163 references indexed in Scilit:
- Structure-based drug screening for G-protein-coupled receptorsTrends in Pharmacological Sciences, 2012
- Determining P-glycoprotein–drug interactions: Evaluation of reconstituted P-glycoprotein in a liposomal system and LLC-MDR1 polarized cell monolayersJournal of Pharmacological and Toxicological Methods, 2012
- Rational Approaches to Improving Selectivity in Drug DesignJournal of Medicinal Chemistry, 2012
- Membrane Position of Ibuprofen Agrees with Suggested Access Path Entrance to Cytochrome P450 2C9 Active SiteThe Journal of Physical Chemistry A, 2011
- Development of the CHARMM Force Field for LipidsThe Journal of Physical Chemistry Letters, 2011
- Pharmacochemistry of the platelet purinergic receptorsPurinergic Signalling, 2011
- Progress in corticotropin-releasing factor-1 antagonist developmentDrug Discovery Today, 2010
- Exploring Molecular Mechanisms of Ligand Recognition by Opioid Receptors with MetadynamicsBiochemistry, 2009
- G protein coupled receptor structure and activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Specific Tryptophan UV-Absorbance Changes Are Probes of the Transition of Rhodopsin to Its Active StateBiochemistry, 1996